104 results
Page 2 of 6
8-K
EX-10.1
c87f2t 1w2qa9gg
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
5yi0mh005haik0y11
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-10.1
djrzd7db g0
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
8-K
EX-99.1
i6ma7lv1sm cjnikh3l9
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-1.1
w8hvg8ymc 54xk
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
424B5
ailtp1v46 dh
8 Apr 21
Prospectus supplement for primary offering
8:58am